SCHEMBL17878734

SCHEMBL17878734

CC(C)(C)OC(=O)NCC[C@H](N)C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.56
SLC1A3 P43003 1/20 0.55
SLC1A1 P43005 1/20 0.55
IDO1 P14902 1/20 0.52
MAPT P10636 2/20 0.52
LTA4H P09960 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
DPP8 Q6V1X1 1/20 0.46
DPP7 Q9UHL4 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
RECQL P46063 1/20 0.46
HTT P42858 1/20 0.45
CTSS P25774 1/20 0.45
NTSR1 P30989 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21164376 0.93 MAPT (0.55) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL20168169 0.92 MAPT (0.59) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL7979181 0.92 MAPT (0.59) SYKSLC1A3SLC1A1IDO1MAPT
Hydrochloric Acid SCHEMBL29401089 0.92 MAPT (0.54) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL5490556 0.92 MAPT (0.59) SYKSLC1A3SLC1A1IDO1MAPT
Hydrochloric Acid SCHEMBL29401553 0.91 MAPT (0.58) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL28251423 0.89 MAPT (0.56) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL28198501 0.89 MAPT (0.56) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL17878732 0.87 SYK (0.65) SYKSLC1A3SLC1A1IDO1MAPT
SCHEMBL29879918 0.87 SYK (0.65) SYKSLC1A3SLC1A1IDO1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 US disclosed
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 US disclosed
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS VIP, AQP1, PEF1 SYK 1484/4885SLC1A3 4591/4885SLC1A1 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.